Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Diem

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|January 23, 2016
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanomaS Diem, B Kasenda, L Spain, et al.
Analytical Chemistry|June 14, 2001
A photometric screening method for dimeric naphthylisoquinoline alkaloids and complete on-line structural elucidation of a dimer in crude plant extracts, by the LC-MS/LC-NMR/LC-CD triadG Bringmann, M Wohlfarth, H Rischer, et al.
Clinical Endocrinology|December 29, 2016
Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanomaD L Morganstein, Z Lai, L Spain, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort studyM Joerger, C Schaer-Thuer, D Koeberle, et al.
Stroke|July 2, 1999
Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomyE Z Oddone, R D Horner, R Sloane, et al.
British Journal of Cancer|April 29, 2016
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapyS Bowyer, P Prithviraj, P Lorigan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|January 23, 2016
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanomaS Diem, B Kasenda, L Spain, et al.
Analytical Chemistry|June 14, 2001
A photometric screening method for dimeric naphthylisoquinoline alkaloids and complete on-line structural elucidation of a dimer in crude plant extracts, by the LC-MS/LC-NMR/LC-CD triadG Bringmann, M Wohlfarth, H Rischer, et al.
Clinical Endocrinology|December 29, 2016
Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanomaD L Morganstein, Z Lai, L Spain, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort studyM Joerger, C Schaer-Thuer, D Koeberle, et al.
Stroke|July 2, 1999
Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomyE Z Oddone, R D Horner, R Sloane, et al.
British Journal of Cancer|April 29, 2016
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapyS Bowyer, P Prithviraj, P Lorigan, et al.
Pageof 2